Smoking cessation: integrating recent advances into clinical practice.
Smoking remains a prevalent habit with serious consequences for public health. There are now effective treatments for nicotine addiction and, in the UK, specialist services for the treatment of smoking cessation are becoming available in all areas. This paper reviews the role of treatments for nicotine addiction in the management of smoking cessation. Recommendations are made for the judicious use of these therapies and also for the rational use of the new UK smoking cessation services.
Coleman
T
T
Department of General Practice and Primary Health Care, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK. tjc3@le.ac.uk
D000279:Administration, Cutaneous; D000928:Antidepressive Agents / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D005731:Ganglionic Stimulants / Q000627:therapeutic use*; D006266:Health Education / Q000379:methods*; D006291:Health Policy; D006801:Humans; D009042:Motivation; D009538:Nicotine / Q000627:therapeutic use*; D009661:Nortriptyline / Q000627:therapeutic use; D016540:Smoking Cessation / Q000379:methods* / Q000706:statistics & numerical data; D000074606:Smoking Prevention; D019966:Substance-Related Disorders / Q000534:rehabilitation*; D006113:United Kingdom
D000928:Antidepressive Agents; D005731:Ganglionic Stimulants; D016642:Bupropion; D009538:Nicotine; D009661:Nortriptyline